AVALT

AVALT is a Boston-based private equity family office and long-term investment firm, not a biotechnology, pharmaceutical, or healthcare operating company. The firm invests its partners' own capital and emphasizes long-duration ownership, collaborative work with management teams, and operational value creation rather than drug discovery or product commercialization. Publicly available materials indicate that AVALT targets lower middle market businesses across multiple sectors, including business services, technology, consumer, industrials, and selectively healthcare services. There is no evidence that AVALT itself develops therapeutics, diagnostics, or medical products, and no biotech-style R&D pipeline was identified. For life sciences diligence purposes, AVALT should be classified as an investor with possible healthcare exposure rather than a health-focused drug developer.